ABB and IBM Partner in Industrial Artificial Intelligence Solutions
Replace first paragraph: ABB and IBM (NYSE:IBM) today announced a strategic collaboration that brings together ABB’s industry leading digital offering, ABB Ability, with IBM Watson Internet of Things cognitive capabilities to unlock new value for customers in utilities, industry and transport & infrastructure.
Customers will benefit from ABB’s deep domain knowledge and extensive portfolio of digital solutions combined with IBM’s expertise in artificial intelligence and machine learning as well as different industry verticals. The first two joint industry solutions powered by ABB Ability and Watson will bring real-time cognitive insights to the factory floor and smart grids.
“This powerful combination marks truly the next level of industrial technology, moving beyond current connected systems that simply gather data, to industrial operations and machines that use data to sense, analyze, optimize and take actions that drive greater uptime, speed and yield for industrial customers,” said ABB CEO Ulrich Spiesshofer. “With an installed base of 70 million connected devices, 70,000 digital control systems and 6,000 enterprise software solutions, ABB is a trusted leader in the industrial space, and has a four decade long history of creating digital solutions for customers. IBM is a leader in artificial intelligence and cognitive computing. Together, IBM and ABB will create powerful solutions for customers to benefit from the Fourth Industrial Revolution.”
New suite of breakthrough solutions
The new suite of breakthrough solutions developed by ABB and IBM will help companies address in a completely new way some of their biggest industrial challenges, such as improving quality control, reducing downtime and increasing speed and yield of industrial processes. These solutions will move beyond current connected systems that simply gather data, to cognitive industrial machines that use data to understand, sense, reason and take actions supporting industrial workers to help eliminate inefficient processes and redundant tasks.
“This important collaboration with ABB will take Watson even deeper into industrial applications – from manufacturing, to utilities, to transportation and more,” said Ginni Rometty, IBM Chairman, president and CEO. “The data generated from industrial companies' products, facilities and systems holds the promise of exponential advances in innovation, efficiency and safety. Only with Watson's broad cognitive capabilities and our platform's unique support for industries can this vast new resource be turned into value, with trust. We are eager to work in partnership with ABB on this new industrial era.”
Bringing real-time cognitive insights to the factory floor
For example, ABB and IBM will leverage Watson’s artificial intelligence to help find defects via real-time production images that are captured through an ABB system, and then analyzed using IBM Watson IoT for Manufacturing. Previously, these inspections were done manually, which was often a slow and error-prone process. By bringing the power of Watson's real time cognitive insights directly to the shop floor in combination with ABB’s industrial automation technology, companies will be better equipped to increase the volume flowing through their production lines while improving accuracy and consistency. As parts flow through the manufacturing process, the solution will alert the manufacturer to critical faults – not visible to the human eye – in the quality of assembly. This enables fast intervention from quality control experts. Easier identification of defects impacts all goods on the production line, and helps improve a company’s competitiveness while helping avoid costly recalls and reputational damage.
Bringing real-time cognitive insights to smart grids
In another example, ABB and IBM will apply Watson’s capabilities to predict supply patterns in electricity generation and demand from historical and weather data, to help utilities optimize the operation and maintenance of today’s smart grids, which are facing the increased complexity created by the new balance of conventional as well as renewable power sources. Forecasts of temperature, sunshine and wind speed will be used to predict consumption demand, which will help utilities determine optimal load management as well as real-time pricing.
About ABB:
ABB (ABBN: SIX Swiss Ex) is a pioneering technology leader in electrification products, robotics and motion, industrial automation and power grids, serving customers in utilities, industry and transport & infrastructure globally. Continuing more than a 125-year history of innovation, ABB today is writing the future of industrial digitalization and driving the Energy and Fourth Industrial Revolutions. ABB operates in more than 100 countries with about 132,000 employees. www.abb.com
About IBM:
For more information, please visit www.ibm.com/iot, www.ibm.com/internet-of-things/iot-solutions/iot-manufacturing/ and follow @IBMIoT on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170424006768/en/
Contact information
ABB
Media Relations, +41 43 317 65 68
media.relations@ch.abb.com
or
Investor
Relations, +41 43 317 71 11
investor.relations@ch.abb.com
or
IBM
Kaveri
Camire, +1 914 625 6395
kcamire@us.ibm.com
or
Erica
Topolski, +1 617 803 7665
ericat@us.ibm.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom